| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NMT2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | SCFD2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | FBXL19 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | POLE4 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | AGO4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | RBM33 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | LDLRAP1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | LHX8 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | ASCL3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | KLF8 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
